Providence and Humana launched a new initiative to standardize and streamline data exchange between payers and providers. The program leverages FHIR-based APIs to create a scalable, real-time system that can be replicated across other healthcare organizations nationwide. The post Providence, Humana Launch Initiative to Standardize Payer-Provider Data Sharing appeared first on MedCity News.
Knownwell’s $25 million in funding was led by CVS Health Ventures and included participation from MassMutual Catalyst Fund, Intermountain Ventures, a16z Bio + Health and Flare Capital Partners. The post Knownwell Secures $25M to Expand Obesity Medicine appeared first on MedCity News.
Roche’s Gazyva, which first reached the market as a blood cancer drug, has expanded its FDA approval to include treatment of the autoimmune disorder lupus nephritis. The CD20-targeting antibody can now compete against a blockbuster GSK drug that is the standard biologic therapy for the debilitating kidney condition. The post FDA Approval for Roche Cancer…
The way forward isn’t bigger models. It’s smaller, smarter ones. Small Language Models (SLMs) are designed to do what LLMs can’t: learn from enterprise data and focus on specific problems. The post LLMs Have Eaten the Internet — Now They’re Starving on Themselves appeared first on MedCity News.
Guideline directed care pathways are a way to shift from transactional PA, where each service requires separate approval, to an episode-of-care model. The post It’s Time to Rethink Prior Authorization for Chronic and Serious Conditions appeared first on MedCity News.
Marlow Hernandez, the founder and former CEO of Cano Health, is facing a jury trial this week over allegations that he fraudulently enriched himself and his family while managing the senior-focused primary care company. Cano filed for bankruptcy last year — an event many industry experts attributed to Hernandez’ poor governance. The post Ex-Cano Health…
Withings Health Solutions added Ilant Health to its Obesity Care Network and shared best practices to improve patient monitoring, engagement and outcomes. The post Withings Health Solutions Expands Obesity Care Network, Launches Best Practices for Treatment Programs appeared first on MedCity News.
BioCryst Pharmaceuticals’ Astria Therapeutics acquisition brings navenibart, a drug in Phase 3 testing for the rare disease hereditary angioedema. The injectable antibody has the potential to match the efficacy of the blockbuster Takeda Pharmaceutical drug that currently dominates the market, but with less burdensome dosing that could encourage HAE patients to switch. The post BioCryst’s…
Clinging to our old models is equivalent to waiting for failure. We need to embrace the tools, team structures, and delivery models that this ongoing crisis demands. The post Stress Test: OBBBA, Rural Fragility, and Innovation appeared first on MedCity News.
Ideas floated by the Trump Administration and Democrats in Congress aim to expand access to fertility treatment as an essential health benefit. But an influx of patients could collide with an already-brittle system of 430,000 annual cycles, 5,000 embryologists, and long-overdue lab upgrades. The post IVF Coverage Proposals Could Squeeze U.S. Fertility Clinics Without Improving…